Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) — Stock Score Summary

Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) has a MoatMap StockRank of 32/100 based on Quality (56/100), Value (13/100), and Momentum (50/100) factor scores. The current signal is SELL. Chengdu Olymvax Biopharma is a vaccine developer. While it has a decent quality score (Q: 56), it does not operate as a CDMO and is subject to heavy domestic regulatory and pricing pressures in China's public healthcare system.

Chengdu Olymvax Biopharmaceuticals Inc. specializes in the research, development, and commercialization of innovative human vaccines, with a focus on bacterial vaccine products like its adsorbed tetanus vaccine. The company leverages a proprietary polysaccharide-protein conjugation technology platform to maintain a competitive edge in the domestic pediatric and infectious disease prevention markets. It is positioned as a specialized biotechnology player capturing market share from traditional vaccine manufacturers in China.

Key Financial Metrics

Price$5.20
Market Cap$2.1B
P/E (TTM)244.57
Price/Book14.91
Return on Equity6.0%
Return on Invested Capital3.6%
Debt/Equity46.71
Gross Margin90.9%
Operating Margin18.7%
Revenue Growth80.4%
Free Cash Flow$-591K

Chengdu Olymvax Biopharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Chengdu Olymvax Biopharmaceuticals Inc.’s (688319.SS) StockRank?
MoatMap’s StockRank for Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) is 32/100, with a Sell signal. It is a composite of Quality (56), Value (13), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does Chengdu Olymvax Biopharmaceuticals Inc. have an economic moat?
Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Chengdu Olymvax Biopharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Chengdu Olymvax Biopharmaceuticals Inc. in?
Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688319.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock